Mechanisms of Cell Death of Chronic Lymphocytic Leukemia Lymphocytes by RNA-Directed Agent, 8-NH2-Adenosine
Authors:
- 15 September 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (18) , 6745-6752
Abstract
Purpose: To determine if RNA-directed nucleoside analogue, 8-NH2-adenosine, induces cell death and if that is accompanied with transcription inhibition of the key survival factors of chronic lymphocytic leukemia (CLL) cells. Experimental Design: Primary lymphocytes from CLL patients were incubated with 10 μmol/L 8-NH2-adenosine for 2, 4, and 6 or 8 hours. The accumulation of analogue triphosphate and the decline in endogenous ATP pool were analyzed by high-performance liquid chromatography. Inhibition of global RNA and protein synthesis was measured and correlated with specific decline in transcript and protein levels of MCL-1, XIAP, and BCL-2, the key survival factors of CLL. These biochemical and molecular end points were related to cell death of these quiescent lymphocytes. Results:In vitro incubations of CLL lymphocytes with 8-NH2-adenosine resulted in rapid but heterogeneous accumulation of 8-NH2-ATP (390-680 μmol/L), with a concomitant decline in endogenous ATP (median, >50% by 4 hour). Global RNA synthesis was decreased in all samples and was associated with a decline in MCL-1, XIAP, and BCL-2 transcripts. There was a parallel decrease in the protein level of MCL-1 and XIAP but not BCL-2. These biochemical changes were accompanied by apoptosis. Conclusion: The evidence of CLL cell death with complementary changes in the expression of survival proteins provides a molecular rationale for using 8-NH2-adenosine as a therapeutic agent for this indolent leukemia.Keywords
This publication has 45 references indexed in Scilit:
- Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATPBlood, 2005
- Chain Termination and Inhibition of Saccharomyces cerevisiae Poly(A) Polymerase by C-8-modified ATP AnalogsJournal of Biological Chemistry, 2004
- Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavageOncogene, 2004
- Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1Nature, 2003
- MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesisLeukemia, 2002
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Innovative Strategies for the Treatment of CLLLeukemia & Lymphoma, 1996
- The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2.Journal of Cell Biology, 1995
- Interleukin‐4 inhibits apoptotic cell death and loss of the bcl‐2 protein in B‐chronic lymphocytic leukaemia cells in vitroBritish Journal of Haematology, 1993
- Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia.Journal of Experimental Medicine, 1990